Disclosure Statement:
It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. Faculty disclosure related to this CME activity is listed below. The intent of this disclosure is to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity.
Dr. Long has served on speakers bureaus for Alcon Pharmaceuticals, AstraZeneca Pharmaceuticals, Genentech, GlaxoSmithKline, Novartis, and Schering-Plough. He has served as an advisory board member for Adheris, AstraZeneca Pharmaceuticals, Genentech, and Schering-Plough.
Release/Expiration Dates
This activity is eligible for CME credit from October 2007 through October 31, 2008.
Additional Topics
> The 30-Minute Office Visit: Strategies and Tools for Asthma Management in Your Practice
> Success in Asthma Control with Challenging Patients
> New Strategies in Asthma Control: Assessment of Impairment and Risk
|
